Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...

M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...

Senator, Dr. Rasha Kelej has been recognized as One of 100 Most Influential Africans for six consecutive years from 2019 till ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

Bringing some payment activities in-house while outsourcing others can help sponsors optimize clinical trial efficiency, ...